Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: A comparison between the Beijing PRIMO and CASCADE cohorts

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 4, 2013, Pages 441-446

  Huang, Xiaojie ^a   Lodi, Sara ^b   Fox, Zoe ^c   Li, Wei ^a   Phillips, Andrew ^c   Porter, Kholoud ^b   Lutsar, Irja ^d   Kelleher, Anthony ^e   Li, Ning ^a   Xu, Xiaoning ^f   Wu, Hao ^a   Johnson, Anne M ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF TARTU   (Estonia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD4+ T cell decline; China; HIV; MSM; Seroconversion

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RATING SCALE; SEROCONVERSION; VIRUS LOAD; VIRUS STRAIN; WESTERN BLOTTING;

ADULT; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; HIV; HOMOSEXUALITY, MALE; HUMANS; MALE; RNA, VIRAL;

EID: 84876359356     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827f5c9a     Document Type: Article

References (26)

1. Liu H, Yang H, Li X, et al. Men who have sex with men and human immunodeficiency virus/sexually transmitted disease control in China. Sex Transm Dis. 2006;33:68-76.
2. Zhang B, Li X, Shi T. A primary estimation of the number of population and HIV prevalence in homosexual and bisexual men in China. Chin J AIDS/STD Prev Control. 2002;8:197-199 [in Chinese].
3. Ministry of Health. China 2010 UNGASS Country Progress Report. April 2010. Available at: http://data.unaids.org/pub/Report/2010/china-2010-country- progress-report-en.pdf.Accessed September 26, 2010.
4. Zhang M, Shang H, Wang Z, et al. Natural history of HIV infection in former plasma donors in rural China. Front Med China. 2010;4:346-350 [in Chinese].
5. Qu W, Robinson M, Zhang FJ. Factors influencing the natural history of HIV-1 infection. Chin Med J (Engl). 2008;121:2613-2621.
6. Zheng X, Zhang J, Wang X, et al. The natural history of HIV infection among IDUs in Ruili, Yunnan province, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2000;21:17-18 [in Chinese].
7. Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
8. Phillips A, Pezzotti P. CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS. 2004;18:51-58.
9. Phillips AN, Staszewski S, Weber R, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001;286:2560-2567.
10. Mussini C, Cossarizza A, Sabin C, et al. Decline of CD4+ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals. AIDS. 2011;25:1041-1049.
11. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet. 2004;363:619-622.
12. Anglaret X, Diagbouga S, Mortier E, et al. CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African participants? J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14: 361-367.
13. Achhra AC, Zhou J, Dabis F, et al. Difference in absolute CD4+ count according to CD4 percentage between Asian and white population HIV-infected participants. J AIDS Clin Res. 2010;1:1-4.
14. Bofill M, Janossy G, Lee CA, et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol. 1992;88:243-252.
15. Lebranchu Y, Thibault G, Degenne D, et al. Abnormalities in CD4+ T lymphocyte subsets in participants with common variable immunodeficiency. Clin Immunol Immunopathol. 1991;61:83-92.
16. Korenromp EL, Williams BG, Schmid GP, et al. Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection-a quantitative review. PLoS One. 2009;17;4:e5950.
17. CASCADE collaboration. Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Med. 2000;1:224-231.
18. Royston P, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28: 964-974.
19. Harrison L, Dunn DT, Green H, et al. Modelling the association between participant characteristics and the change over time in a disease measure using observational cohort data. Stat Med. 2009;28:3260-3275.
20. Kam KM, Wong KH, Li PC, et al. Proposed CD4(+) T-cell criteria for staging human immunodeficiency virus-infected Chinese adults. Clin Immunol Immunopathol. 1998;89:11-22.
21. Wong KH, Chan KC, Cheng KL, et al. Establishing CD4 thresholds for highly active antiretroviral therapy initiation in a cohort of HIV-infected adult Chinese in Hong Kong. AIDS Patient Care STDS. 2007;21:106-115.
22. Kam KM, Leung WL, Kwok MY, et al. Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus infected Chinese adults. Clin Diagn Lab Immunol. 1996;3:326-330.
23. Chang WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol. 2004;11:168-173.
24. Moore RD, Keruly JC. CD4 cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44:441-446.
25. Waters L, Mandalia S, Randell P, et al. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen. Clin Infect Dis. 2008;46:1617-1623.
26. CASCADE Collaboration. The relationships between the HIV test interval, demographic factors and HIV disease progression. Epidemiol Infect. 2001;127:91-100.